505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA
Similar to 505(b)(2)
ACE - Automated Commercial EnvironmentACE - Adverse Clinical Event
ACEP - American College of Emergency Physicians
ACF - Administration for Children and Families
ACG - American College of Gastroenterology
ACGME - Accreditation Council for Graduate Medical Education
ACIP - Advisory Committee on Immunization Practices CDC
View all in FDA